Maven Securities’s NeueHealth NEUE Stock Holding History

Maven Securities’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-180	Closed	-$250K	–	1305
2021 Q2	$250K	Buy	+180	New	+$247K	0.01%	881

Other funds holding NEUE

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

DIC

Deer IX & Co Larchmont, New York $971M AUM 24.77% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Maven Securities's NEUE Position: Q3 2021 in Review

Maven Securities sold out of NeueHealth (NEUE) in Q3 2021, closing a stake of 180 shares — an estimated $250K sold.

Maven Securities first reported a position in NEUE in Q2 2021 and held it in 1 quarter. The position peaked at $250K in Q2 2021. 102 funds tracked by Wall St. Rank hold NEUE as of Q3 2021.

Maven Securities reported no remaining NeueHealth position as of Q3 2021 after selling out during the quarter.
Maven Securities sold 180 NeueHealth shares in Q3 2021, an estimated $250K.
Maven Securities first reported a position in NeueHealth in Q2 2021 and held it in 1 quarter.
Maven Securities's NeueHealth position peaked at $250K in Q2 2021.
102 funds tracked by Wall St. Rank held NeueHealth as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.